Novartis to acquire The Medicines Company for $9.7bn with eye on inclisiran

Novartis acquisition of The Medicines Company : Swiss drugmaker Novartis signed a deal worth $9.7 billion to acquire US biopharma company The Medicines Company, as ... Read More